SEC 13F Intelligence

Royce & Associates LP / TECH

Royce & Associates LP’s Bio-Techne Corp Position

Does Royce & Associates LP own Bio-Techne Corp (TECH)? Yes759.7K shares worth $40M (+0.39% of its 13F portfolio) as of Q1 2026, up from 678.5K shares the prior filed quarter.

Position Value
$40M
Q1 2026
Shares
759.7K
% of Portfolio
+0.39%
Quarters Held
30
currently held

Position History TECH

Reported value by quarter
Q4 ’18: $43MQ4 ’18Q1 ’19: $53MQ2 ’19: $52MQ3 ’19: $51MQ4 ’19: $49MQ4 ’19Q1 ’20: $42MQ2 ’20: $56MQ3 ’20: $52MQ4 ’20: $61MQ4 ’20Q1 ’21: $69MQ2 ’21: $57MQ3 ’21: $38MQ4 ’21: $40MQ4 ’21Q1 ’22: $34MQ2 ’22: $33MQ3 ’22: $29MQ4 ’22: $37,471Q4 ’22Q1 ’23: $52MQ2 ’23: $45MQ3 ’23: $46MQ4 ’23: $53MQ4 ’23Q1 ’24: $56MQ2 ’24: $59MQ3 ’24: $68MQ4 ’24: $62MQ4 ’24Q1 ’25: $51MQ2 ’25: $45MQ3 ’25: $37MQ4 ’25: $40MQ4 ’25Q1 ’26: $40Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026759.7K$40M+0.39%
Q4 2025678.5K$40M+0.40%
Q3 2025660.0K$37M+0.37%
Q2 2025870.9K$45M+0.46%
Q1 2025870.2K$51M+0.55%
Q4 2024860.8K$62M+0.58%
Q3 2024845.4K$68M+0.61%
Q2 2024828.1K$59M+0.55%
Q1 2024796.6K$56M+0.50%
Q4 2023683.5K$53M+0.49%
Q3 2023674.3K$46M+0.47%
Q2 2023545.6K$45M+0.43%
Q1 2023695.2K$52M+0.52%
Q4 2022452.1K$37,471+0.39%
Q3 2022101.5K$29M+0.33%
Q2 202295.9K$33M+0.34%
Q1 202279.4K$34M+0.29%
Q4 202176.4K$40M+0.30%
Q3 202178.9K$38M+0.29%
Q2 2021127.3K$57M+0.39%
Q1 2021180.2K$69M+0.46%
Q4 2020190.6K$61M+0.50%
Q3 2020211.5K$52M+0.57%
Q2 2020210.6K$56M+0.61%
Q1 2020223.0K$42M+0.58%
Q4 2019224.9K$49M+0.44%
Q3 2019260.2K$51M+0.47%
Q2 2019247.4K$52M+0.47%
Q1 2019265.4K$53M+0.45%
Q4 2018298.8K$43M+0.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Royce & Associates LP’s full portfolio or all institutional holders of TECH.